100% Quality Guarantee
PhD-Level Technical Support
Key Features

FITC Anti-Human CD197/CCR7 Antibody [G043H7] (AGEL1802)

SKU AGEL1802
Product Type Antibody
Antibody Type Monoclonal Antibody
Applications FC
Reactivity Human
Host Species Mouse
Isotype IgG2a,k
Clone G043H7
Conjugation FITC
€88 - €383

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

FITC Anti-Human CD197/CCR7 Antibody [G043H7]

The Human CD197 (CCR7) Monoclonal Antibody (FITC Conjugated) is a cutting-edge tool designed for immunological research, particularly focusing on the CD197 protein, which plays a vital role in immune cell trafficking and migration. This monoclonal antibody, conjugated with FITC for fluorescent detection, is specifically engineered for use in flow cytometry and immunofluorescence applications.CD197, also known as CCR7, is a chemokine receptor expressed on various immune cell types, including T cells and dendritic cells, and is instrumental in facilitating their proper homing to lymphoid tissues. This antibody's high specificity and affinity for human CD197 make it an invaluable resource for investigating immune cell movement and lymphoid organ development processes.

By utilizing this antibody, researchers can gain insight into the intricate mechanisms underlying immune cell migration and their impact on immune responses in health and disease. The ability to accurately detect and analyze CD197 expression in different cell populations opens up new avenues for studying immune system dynamics, inflammation, and potentially developing targeted therapies for conditions where immune cell trafficking is dysregulated.In summary, the Human CD197 (CCR7) Monoclonal Antibody (FITC Conjugated) is a sophisticated research tool that holds promise for advancing our understanding of immune cell behavior and its implications for various physiological and pathological processes.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose